Generic Antibodies
Generic Antibodies Companies (4)
Generic Antibodies News
-
News ProBioGen selected for development and large-scale manufacturing services
The Contract Development and Manufacturing Organization (CDMO) and technology provider will use its CHO.RiGHT expression platform for high-titer cell line development. -
News Sphere Fluidics expands into additional facility
New offices at leading science hub support the company’s rapid growth following recent investment. -
News Rapid adoption of Carterra’s LSA instrument drives European expansion
Company's antibody screening platform minimizes the risk of missing a blockbuster. -
News Leaf Expression promises rich harvest for drug industry
Company's multimillion pound purpose-built facility becomes fully operational amidst growing interest worldwide in its potentially game-changing plant transient expression technology, Hypertrans.
Generic Antibodies Products (9)
-
Product Metformin HCl
Vistin Pharma AS provides wide range of products which includes Metformin API. It is used for first-line treatment of diabetes ll. Contact us for more information.
-
Product Antibody / Monoclonal antibody therapeutics services
Monoclonal antibody therapeutics: We continually invest in advanced analytical instrumentation that allows us to deliver mAb analytical data with the highest degree of sensitivity, accuracy and resolution. Our experience spans recombinant monoclonal antibodies and related products such as biosimilars, ...
-
Product Metformin DC 95% and 92,6% (Direct Compressible)
Vistin Pharma AS provides wide range of products which includes metformin dc (direct compressible). Contact us for more information.
-
Product Comparability Studies for Biopharmaceuticals
We design bespoke analytical programmes that ensure that the relevant quality attributes for your drug substance or product are evaluated to support your manufacturing process changes. We select analytics referenced by the ICH Q6B to examine the product's structural features (primary, secondary and&nb...
-
Product VHH antibody, nanobody, discovery services
Cortalix provides end-to-end nanobody discovery services based on proprietary synthetic and immune VHH libraries. We guide clients from target definition to high-affinity lead candidates, including binder selection, affinity maturation, and engineering into multivalent or functional formats. Our platform s...
-
Product VHH antibody, nanobody, production services
Cortalix provides flexible VHH nanobody production services tailored to your application and quantity needs. We produce research-grade and preclinical-quality VHHs using optimized microbial expression systems, with optional QC including SEC, endotoxin, and functional binding assays. Available as standalone...
-
Product VHH antibody, nanobody, functionalization services
Cortalix offers tailored nanobody functionalization services to support downstream applications in imaging, therapy, and analytics. We conjugate VHHs to chelators (DOTA, NOTA), fluorophores, enzymes, or beads using optimized chemistries that preserve binding activity. All modifications are QC-tested for in...
-
Product High-Throughput Recombinant Antibody Production
Biointron's high-throughput antibody production provides the most cost-effective option for recombinant antibodies, where you may choose to deliver either supernatant or purified antibodies (ug to gram level). From gene synthesis to purified antibodies (IgG, scFv, VHH, etc.), it takes as fast as 2 weeks. A...
-
Product Single B Cell Screening
Biointron offers a high-throughput, fully integrated platform for accelerating antibody discovery. Biointron's high-throughput single B cell screening platform can screen 2*10^6 plasma B-cells from immunized animals. Antigen specific antibody-secreting cells can be isolated. It allows the detection of pote...
Upcoming Events
-
CPHI & PMEC China 2026
Shanghai New International Expo Center
16 Jun 2026 - 18 Jun 2026 -
CPHI South East Asia 2026
QSNCC, Bangkok, Thailand
08 Jul 2026 - 10 Jul 2026 -
CPHI Korea 2026
COEX, Seoul, Korea
25 Aug 2026 - 27 Aug 2026

